LIPFENDRA
NDC 0006-5084, LIPFENDRA, tablet, film coated, from Merck Sharp & Dohme LLC.
- Product NDC
- 0006-5084
- Status
- Listed
- Labeler
- Merck Sharp & Dohme LLC
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA220848
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0006-5084 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ENLICITIDE DECANOATE20 mg/1
Pharmacologic classes
PCSK9 Inhibitor [EPC]; PCSK9 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0006-5084-01 | 00006508401 | 30 TABLET, FILM COATED in 1 BOTTLE (0006-5084-01) |
| 0006-5084-59 | 00006508459 | 1 BOTTLE in 1 CARTON (0006-5084-59) / 7 TABLET, FILM COATED in 1 BOTTLE (0006-5084-58) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/100ec543-fbd0-44fc-b740-db9cdff39145
Use it
Look up 0006-5084 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0006-5084 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0006-5084. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.